Glycomet SR(Metformin) tablets are primarily prescribed for the effective management of type 2 diabetes mellitus. By assisting in regulating blood sugar levels, it plays a crucial role in preventing the onset of serious complications associated with diabetes.
Find out more about Glycomet SR
Glycomet SR 500/850/1000mg: Each uncoated tablet contains metformin hydrochloride IP (as sustained release) 500/850/1000mg.
Metformin is the only pharmacologic agent recommended for the prevention or postponement of T2D. Metformin is the first line of treatment for prediabetes patients in appropriate cases to reduce the risk of type 2 diabetes progression.2
Metformin is indicated as monotherapy to lower blood glucose in patients with type 2 diabetes mellitus whose blood glucose cannot be satisfactorily managed on diet and exercise. It may be used concomitantly with a sulphonyl urea when diet and Metformin or a sulphonyl urea monotherapy do not result in adequate glycemic control.
Metformin effectively prevents diabetes, especially in younger individuals with higher body weights
Metformin supports glycemic hygiene, vascular hygiene, and vasculometabolic hygiene
RSSDI (India, 2020)4
Diabetes prevention Program5
Metformin for preventing T2DM recommended for prediabetic individuals, especially with BMI ≥35 kg/m²,<60 years old, or with prior gestational diabetes4.
Metformin 500 mg, twice daily for overweight/obese individuals with IFG + IGT or IFG + HbA1c >5.7%5.
For rapid progression from prediabetes to diabetes, metformin is considered alongside lifestyle changes, especially for those with combined IFG and IGT, particularly in high-risk groups2
ADA- American Diabetes Association, RSSDI- Research Society for the Study of Diabetes in India, ICMR- Indian Council of Medical Research.
© 2024 - Medical Dialogues. All Rights Reserved.